摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-苯并噻吩-2-磺酰氯 | 90001-64-2

中文名称
1-苯并噻吩-2-磺酰氯
中文别名
苯并噻吩-2-磺酰氯
英文名称
1-benzothiophene-2-sulfonyl chloride
英文别名
benzo[b]thiophene-2-sulfonyl chloride;benzothiophene-2-sulfonyl chloride;1-benzothiophen-2-ylsulphonyl chloride
1-苯并噻吩-2-磺酰氯化学式
CAS
90001-64-2
化学式
C8H5ClO2S2
mdl
MFCD03659701
分子量
232.711
InChiKey
FKIIVBOPAHICHQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    70.8
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi,C
  • 安全说明:
    S26,S36/37/39,S45
  • 危险类别码:
    R34
  • 海关编码:
    2934999090

SDS

SDS:b27c42a0fb3af7e9ca74dbc5d1b678ae
查看
Name: 1-Benzothiophene-2-sulfonyl chloride 97% Material Safety Data Sheet
Synonym:
CAS: 90001-64-2
Section 1 - Chemical Product MSDS Name:1-Benzothiophene-2-sulfonyl chloride 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
90001-64-2 1-Benzothiophene-2-sulfonyl chloride 97% unlisted
Hazard Symbols: C
Risk Phrases: 34

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area. Store under an inert atmosphere.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 90001-64-2: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Needles
Color: pink
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 74.8 - 75.7 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H5ClO2S2
Molecular Weight: 232.71

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 90001-64-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-Benzothiophene-2-sulfonyl chloride - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3261
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 90001-64-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 90001-64-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 90001-64-2 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-苯并噻吩-2-磺酰氯盐酸 作用下, 以 二氯甲烷甲醇 为溶剂, 反应 3.3h, 生成 N-(2-aminoethyl)-2-benzo[b]thiophenesulfonamide hydrochloride
    参考文献:
    名称:
    NOVEL AMINE DERIVATIVE HAVING HUMAN BETA-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME
    摘要:
    本发明旨在提供一种新型低分子量胺衍生物,该衍生物被很好地吸收,毒性低,并且具有极高选择性的优异人类β-色氨酸蛋白酶抑制活性,其药学上可接受的盐,以及含有该衍生物作为活性成分的药物。本发明的药物可作为一种预防/治疗剂,用于被认为是由β-色氨酸蛋白酶引起的危机和发展的疾病,例如呼吸道疾病、过敏性疾病、炎症性肠病、皮肤过度增生疾病、血管水肿和类风湿性关节炎。
    公开号:
    EP1445250A1
  • 作为产物:
    描述:
    苯并噻吩正丁基锂 、 2,4,6-trichlorophenyl chlorosulfate 作用下, 以 四氢呋喃2-甲基四氢呋喃正己烷 为溶剂, 反应 4.0h, 生成 1-苯并噻吩-2-磺酰氯
    参考文献:
    名称:
    由有机锌试剂和2,4,6-三氯苯基氯硫酸盐合成杂芳基磺酰胺
    摘要:
    描述了一种使用2,4,6-三氯苯基氯硫酸盐(TCPC)制备芳基和杂芳基磺酰胺的方法。2-吡啶基锌试剂与TCPC的反应生成2,4,6-三氯苯基(TCP)吡啶-2-磺酸盐,并且母体吡啶-2-磺酸盐显示与胺反应。较少电子富集的芳基锌和杂芳基锌试剂与TCPC反应生成磺酰氯,该磺酰氯可就地转化为磺酰胺。
    DOI:
    10.1021/acs.orglett.5b01540
  • 作为试剂:
    描述:
    7-(3-(S)-amino-2-oxopyrrolidin-1-ylmethyl)-2-chloro-quinoline hydrochloride 以 1-苯并噻吩-2-磺酰氯二氯甲烷氯仿 为溶剂, 生成 Benzo[b]thiophene-2-sulfonic acid [1-(2-chloro-quinolin-7-ylmethyl)-2-oxopyrrolidin-3-(S)-yl]-amide
    参考文献:
    名称:
    Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
    摘要:
    本文中的化合物具有有用的药理活性,因此被纳入药物组合物中,并用于治疗患有某些医学疾病的患者。更具体地说,它们是凝血因子Xa活性的抑制剂。本发明涉及具有I式化合物的化合物、含有I式化合物的组合物,以及它们的用途,用于治疗患有或受到生理状况影响的患者,这些生理状况可以通过给予凝血因子Xa活性抑制剂来改善。
    公开号:
    US06281227B1
点击查看最新优质反应信息

文献信息

  • SUBSTITUTED SULFONAMIDE COMPOUNDS
    申请人:OBERBOERSCH Stefan
    公开号:US20080153843A1
    公开(公告)日:2008-06-26
    Substituted sulfonamide derivatives, a process for their preparation, pharmaceutical compositions containing these compounds, and to the use of substituted sulfonamide derivatives in the treatment or inhibition of pain and/or various disorders or disease states.
    磺胺取代物,其制备方法,含有这些化合物的药物组合物,以及磺胺取代物在治疗或抑制疼痛和/或各种疾病或疾病状态中的用途。
  • Parallel Solution-Phase Synthesis and General Biological Activity of a Uridine Antibiotic Analog Library
    作者:Omar Moukha-chafiq、Robert C. Reynolds
    DOI:10.1021/co4001452
    日期:2014.5.12
    coupling of the amino terminus of d-phenylalanine methyl ester to the free 5′-carboxylic acid moiety of 33 followed by sodium hydroxide treatment led to carboxylic acid analog 77. Hydrolysis of this material gave analog 78. The intermediate 77 served as the precursor for the preparation of novel dipeptidyl uridine analogs 79–99 through peptide coupling reactions to diverse amine reactants. None of the described
    在 NIH 路线图计划的中试规模库 (PSL) 计划下,以溶液相方式从胺2和羧酸33和77合成了一个包含 94 种尿苷抗生素类似物的小型库。多样醛,磺酰氯,和羧酸反应物套缩合,2,酸介导的水解导致后,向目标化合物3 - 32以良好的收率和高的纯度。同样,用不同的胺和磺胺处理33得到34 – 75。d氨基末端的偶联-苯丙氨酸甲酯到33的游离 5'-羧酸部分,然后用氢氧化钠处理产生羧酸类似物77。该材料的水解得到类似物78。中间77担任该前体为二肽基新颖尿苷类似物的制备79 - 99通过肽偶联到不同的胺反应剂反应。所描述的化合物均未显示出显着的抗癌或抗疟活性。通过 NIH MLPCN 计划提供和报告的初级筛选中的酶和受体,许多样品表现出各种有希望的抑制性、激动剂、拮抗剂或激活剂特性。
  • NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES
    申请人:Hebeisen Paul
    公开号:US20090143448A1
    公开(公告)日:2009-06-04
    Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R 1 to R 3 have the significance given in claim 1 and which can be used in the form of pharmaceutical compositions.
    式(I)的化合物以及其药用可接受的盐和酯,其中R1至R3具有权利要求1中给定的含义,并可用于制成药物组合物。
  • Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
    申请人:——
    公开号:US20020095041A1
    公开(公告)日:2002-07-18
    Biphenylsulfonamides and methods for modulating or altering the activity of the endothelin family of peptides are provided. In particular, bicyclic or tricyclic carbon or heterocyclic ring biphenylsulfonamides and methods using these sulfonamides for inhibiting the binding of an endothelin peptide to an endothelin receptor by contacting the receptor with the sulfonamide are provided. Methods for treating endothelin-mediated disorders by administering effective amounts of one or more of these sulfonamides or prodrugs thereof that inhibit or increase the activity of endothelin are also provided.
    提供了二苯基磺胺类化合物和调节或改变内皮素家族肽活性的方法。具体包括使用双环或三环碳或杂环环二苯基磺胺类化合物的方法,通过将该磺胺类化合物与内皮素受体接触来抑制内皮素肽与内皮素受体的结合。还提供了通过给予有效剂量的这些磺胺类化合物或其前药来治疗内皮素介导的疾病的方法,这些化合物能够抑制或增加内皮素的活性。
  • [EN] PNA MONOMER AND PRECURSOR<br/>[FR] MONOMERE ET PRECURSEUR PNA
    申请人:PANAGENE INC
    公开号:WO2003091231A1
    公开(公告)日:2003-11-06
    This application relates to monomers of the general formula (I) for the preparation PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: (I) wherein E is nitrogen or C-R'; J is sulfur or oxygen; R', Rl, R2, R3, R4 is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy, phenyl or halogenated phenyl, RS is H or protected or unprotected side chain of natural or unnatural a-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.
    该应用程序涉及通用式(I)的单体,用于制备PNA(肽核酸)寡聚体,并提供了合成预定义序列PNA寡聚体和随机序列PNA寡聚体的方法:(I)其中E为氮或C-R'; J为硫或氧; R',Rl,R2,R3,R4独立地为H,卤素,烷基,硝基,腈基,烷氧基,卤代烷基,卤代烷氧基,苯基或卤代苯基,RS为H或天然或非天然α-氨基酸的保护或未保护侧链; B为天然或非天然核碱基,其中当所述核碱基具有外环氨基功能时,所述功能由对酸敏感但在巯基存在下对弱到中等碱稳定的保护基保护。
查看更多

同类化合物